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Background: We studied the value of routine biochemical variables albumin, C-reactive protein (CRP) and lactate
dehydrogenase (LDH) to improve prediction and monitoring of acute respiratory distress syndrome (ARDS) severity
in the intensive care unit.
Methods: In 101 critically ill patients, with or at risk for ARDS after new onset fever, data were collected on days
(D) 0, 1, 2, and 7 after inclusion. ARDS was defined by the Berlin definition and lung injury score (LIS).
Results: At baseline, 48 patients had mild to severe ARDS according to Berlin and 87 according to LIS (Rs = 0.54,
P < 0.001). Low baseline albumin levels were moderately associated with maximum Berlin and LIS categories within
7 days; an elevated CRP level was moderately associated with maximum Berlin categories only. The day-by-day
Berlin and LIS categories were inversely associated with albumin levels (P = 0.01, P < 0.001) and directly with CRP
levels (P = 0.02, P = 0.04, respectively). Low albumin levels had monitoring value for ARDS severity on all study days
(area under the receiver operating characteristic curve, AUROC, 0.62-0.82, P < 0.001-0.03), whereas supranormal CRP levels
performed less . When the Berlin or LIS category increased, albumin levels decreased ≥1 g/L (AUROC 0.72-0.77, P = 0.001)
and CRP increased ≥104 mg/L (only significant for Berlin, AUROC 0.69, P = 0.04). When the LIS decreased, albumin levels
increased ≥1 g/L (AUROC 0.68, P = 0.02). LDH was higher in 28-day non-survivors than survivors (P = 0.007).
Conclusions: Overall, albumin may be of greater value than CRP in predicting and monitoring the severity and course of
ARDS in critically patients with or at risk for the syndrome after new onset fever. Albumin levels below 20 g/L as well as a
decline over a week are associated with ARDS of increasing severity, irrespective of its definition. LDH levels predicted
28-day mortality.
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The acute respiratory distress syndrome (ARDS) is caused
by alveolocapillary inflammation and increased permeabil-
ity following a direct pulmonary or extrapulmonary insult.
Many conditions, such as sepsis and trauma, which in-
crease the risk for developing or worsening of ARDS are
associated with fever. Fever, in turn, may aggravate alveo-
locapillary inflammation [1,2]. The recent Berlin definition
and the old, more elaborate lung injury score (LIS) [2-8]
are used to diagnose and classify ARDS. One of the draw-
backs of the Berlin definition, even though moderately re-
lating to lung edema [9], is its dependency on ventilator
settings in mechanically ventilated patients (with positive
end-expiratory pressure, PEEP, affecting the oxygenation
ratio) and lack of a specific index of severity as the total
respiratory compliance [5,7]. PEEP and compliance are in-
corporated in the LIS [3], which may therefore constitute
a refined but more complex measure of clinical severity
that correlates with alveolocapillary permeability and can
be assessed at the bedside if the measurement technique is
available [10,11]. The Berlin definition further includes
preconditions and bilateral consolidations, even in the
lowest class, while the lowest class of LIS may contain uni-
lateral consolidation. Another limitation of these clinical
classifications systems is their use of chest radiographs in
the diagnostic work up. Interobserver agreement on chest
imaging is poor, leading to frequent false positives and
false negatives [12,13]. The systems have been compared
and only partial overlap has been acknowledged [1,4]. Not-
ably, agreement between clinical ARDS definitions and
autopsy findings of diffuse alveolar damage is moderate
[4,8]. Moreover, clinicians may underdiagnose ARDS, par-
ticularly when occurring late in the intensive care unit
(ICU), and may be poorly able to quantify its severity and
course, particularly when clinical classification systems are
not commonly used [4,6-8,14].
Therefore, the search for accurate biomarkers reflecting
the severity and course of alveolocapillary inflammation
and increased permeability underlying the non-cardiogenic
pulmonary edema of ARDS is ongoing [6,15]. We and
others described that circulating albumin levels, in cross-
sectional studies, inversely relates to increased alveolocapil-
lary permeability and that hypoalbuminemia predict ARDS
and edema formation in at risk patients [9,11,16-19]. Ex-
travasation of albumin following increased permeability
lowers albumin levels and the resultant low plasma colloid
osmotic pressure promotes edema formation. Inflamma-
tion and injury markers such as C-reactive protein (CRP)
[18,20-25] and lactate dehydrogenase (LDH) [24,26]
have been suggested to help predict early onset ARDS and
its outcome in cross-sectional studies. Since both clinical
classifications systems allow coincident ARDS and hydro-
static edema, inflammatory markers such as CRP may be
of value in separating non-hydrostatic from hydrostaticedema [15,23]. Meduri et al. [20] showed a decline in CRP
and LIS in early ARDS patients responding to corticoste-
roids. However, the ARDS monitoring value of these rou-
tine biochemical markers, often available on a daily basis
in the intensive care unit (ICU), is unknown. Associations
with the severity and course of ARDS, if any, could be of
value in monitoring and therefore in the management of
the syndrome at the bedside.
The aim of the present study is to determine whether
albumin, CRP and LDH levels are associated with the se-
verity and course of ARDS in critically ill patients after
new onset fever with or considered at risk for the syn-
drome defined by the Berlin and the LIS criteria. The hy-
pothesis was that decreasing albumin and increasing CRP
and LDH reflect, accurately enough for clinical use, in-
creasing severity of ARDS if judged by both clinical classi-
fication systems. Indeed, we reasoned that the overlap of
systems would be a better reference standard for potential
biomarkers than either system alone.
Methods
This was a prospective observational cohort study on the
predictive and monitoring value of routine biochemical pa-
rameters for ARDS severity. The study was subsidiary to
the original study on biomarkers of infection and subse-
quent organ failure in 101 consecutive critically ill patients
with ICU-acquired fever [27]. Fever is a warning sign of in-
flammation. Many conditions associated with the develop-
ment of ARDS, i,e, sepsis, trauma, burn injury, transfusion
related lung injury amongst others, are accompanied by
fever due to inflammation. The study was approved by the
local Ethical Committee of the VU University Medical
Center, Amsterdam. All patients or closest relatives
gave written informed consent and a full description of the
protocol can be found in a previous publication on this
cohort evaluating biomarkers of infection only [27]. To
briefly summarize: the main inclusion criterion was new
onset fever: a body temperature >38.3°C measured rectally,
while body temperature in the first 24 hrs of ICU stay
was <37.5°C. Exclusion criteria were: age under 18 years,
pregnancy, and life expectancy of <24 hours. Patients were
taken care of by intensivists unaware of test results accord-
ing to international and local standards. Albumin infusion
was no part of standard treatment.
Protocol
The day of new onset fever was marked day 0 (D0).
Within 12 hours of meeting inclusion criteria we re-
corded: demographic variables, risk factors, and base-
line characteristics. Disease severity was expressed by the
simplified acute physiology score (SAPS) II on admission.
The sequential organ failure assessment (SOFA) scores
were used to monitor organ failure. Mechanical ventilation
was pressure guided (control or support) and protective
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graphs collected on study days were reviewed by two au-
thors (SHH and ABJG) blinded to the study results in an
effort to exclude severe fluid overload or signs of congest-
ive heart failure in classifying alveolar consolidations, In
addition to the chest radiographs we used the central ven-
ous pressure (CVP), which was routinely measured in 83%
of patients, to rule out severe fluid overload. The routine
biochemical variables, albumin, CRP, LDH, and respiratory
parameters like ventilator settings and daily chest radio-
graphs were collected on D0, 1, 2, and 7. Total respiratory
dynamic compliance was calculated from tidal volume/
(plateau pressure-positive end-expiratory pressure), mL/
cmH2O. The need for additional imaging and collection of
specimen for cultures was decided upon by treating physi-
cians blinded to study results. In case culture and/or im-
aging results were positive we considered the day of their
collection the day of diagnosis. Sepsis is the simultaneous
presence of either clinically suspected or proven infection
and the systemic inflammatory response syndrome. Pa-
tients were considered suffering shock when a systolic ar-
terial pressure <90 mmHg or a mean arterial pressure
(MAP) <65 mmHg was observed for at least one hour des-
pite adequate fluid resuscitation and/or need of vasopres-
sor administration. All definitions, including infections,
are in line with American Society of Chest Physicians/So-
ciety of Critical Care Medicine criteria [28,29]. For the
sake of clarity, pneumonia is either community-, hospital-
or ventilator-acquired. To define ARDS severity on study
days, both the Berlin definition and the LIS were used.
The Berlin definition divides patients into 4 categories that
reflect the severity of the syndrome: no ARDS (Berlin 0,
not fulfilling preconditions or PaO2/FIO2 > 300 mmHg),
mild ARDS (Berlin 1, 200 mmHg < PaO2/FIO2 ≤ 300
mmHg), moderate ARDS (Berlin 2, 100 mm Hg < PaO2/
FIO2 ≤ 200 mm Hg), and severe ARDS (Berlin 3, PaO2/
FIO2 ≤ 100 mmHg). Patients suffer from ARDS if its onset
is within 1 week of a known clinical insult or worsening
of respiratory symptoms, there are bilateral opacities on
chest radiograph not fully explained by cardiac failure of
fluid overload, and the PEEP level is ≥5 cmH2O [7]. We
also calculated the LIS [3]; an average based on classi-
fication of patients by the number of quadrants with
alveolar consolidation on the anterior-posterior chest
radiograph, severity of hypoxemia, pulmonary compliance
(tidal volume/(peak inspiratory pressure-PEEP)), and PEEP
level. We used the lowest PaO2/FIO2 measured on study
days and recorded the corresponding PEEP levels and
compliance at the time of sampling. Based on their LIS,
patients were divided into three categories that reflect
disease severity: no lung injury (LIS ≤1), mild ARDS (LIS
1-2.5), and severe ARDS (LIS >2.5) [6]. Follow up was
until day 28 and we checked the clinical state or date of
death for all patients.Biochemistry
Albumin was measured by using Albumin/BCP (Roche
Diagnostics, Mannheim, Germany); normal values are
35-47 g/L. CRP was measured using an immunoturbidi-
metric assay by Modular analytics < P > Roche diagnos-
tics (Mannheim, Germany) and normal values are <5 mg/
L. LDH was measured using lactate dehydrogenase opti-
mized (Roche diagnostics, Mannheim, Germany); the
normal range is 240- 480 U/L.Statistical analysis
Data are expressed as median (inter quartile range) or
number (percentage) where appropriate. Non-normally
distributed data were logarithmically transformed where
appropriate. To study group differences in continuous var-
iables we performed the Kruskal-Wallis test followed by a
Mann-Whitney U test and for categorical variables we
used the X2 test. We used the Spearman’s rank correlation
for non-normally distributed data to indicate any overlap
between the Berlin and LIS categories. First, to evaluate
the diagnostic value of day 0 routine biochemical variable
levels for the maximum ARDS severity within one week
after inclusion, we calculated the area under the receiver
operating characteristic curve (AUROC) and associated
statistical predictive variables, such as optimal cutoff
values, sensitivity, specificity, positive and negative pre-
dictive values. We performed the AUROC analyses using
MedCalc for Windows, version 13 (MedCalc Software,
Ostend, Belgium). The optimal diagnostic cutoff value was
derived from the optimal Youden’s index ( J = sensitivity +
specificity-1; were J = 1 represents perfect diagnostic test
accuracy, ref [30]). Prior to data-analysis and in line with
the literature we decided that an AUROC >0.65 was cli-
nically relevant and >0.70 of good discriminative value.
Subsequently, to study the monitoring value of routine bio-
chemical markers for ARDS longitudinally, we performed
generalized estimating equations (GEE), taking repeated
measures in the same patient and first order interactions
into account. To further study the monitoring value of the
biochemical markers for ARDS severity, we calculated the
AUROCs on individual study days. Finally, we compared
the change in biomarker levels (increase or decrease) over
7 days between patients with increasing, equal or decreas-
ing ARDS severity. To study this association we calculated
the day 0 to day 7 change in routine biochemical variables
(Δ =D0-7) and the change in Berlin and LIS category and
tested for differences between groups. We compared rou-
tine biochemical variable levels between 28-day survivors
and non-survivors and between 28-day survivors and non-
survivors with a maximum Berlin ≥1 or maximum LIS >1.
Since LDH did not appear useful in diagnosing ARDS se-
verity and course, associations with outcome are reported
only. All tests were two-sided and P-values ≤0.05 were




Baseline patient characteristics according to Berlin cat-
egories are presented in Table 1. Of the 101 patients, 53
(52%) had no ARDS on D0, 9 (9%) mild ARDS, 32 (32%)
moderate, and 7 (7%) severe ARDS. In patients with se-
vere ARDS (Berlin 3), SOFA scores were higher than inTable 1 Patient characteristics according to Berlin and LIS cat
Berlin category 0 1
N = 53 N
Age, years 61 (30) 7
Sex, male 39 (74) 5
SAPS II admission 46 (20) 5
SOFA D0 7 (4) 8
ICU days until inclusion 6 (12) 7
CVP D0, mmHg 9 (5) 5
CVP D1, mmHg 8 (5) 6
CVP D2, mmHg 7 (4) 9
CVP D7, mmHg 7 (4) 9
Vasopressor use D0-7 28 (53) 6
Renal replacement therapy D0-7 3 (6) 1
Albumin 20% administration (100 mL) D0-7 3 (6) 2
Corticosteroids use D -7-0 23 (43) 5
Corticosteroid use D 0-7 23 (43) 7
28-day mortality 9 (17) 4
LIS category LIS <1 L
N =14 N
Age, years 62 (28) 6
Sex, man 10 (71) 4
SAPS II at admission 49 (20) 4
SOFA D0 5 (2) 8
ICU days until inclusion 6 (14) 7
CVP D0, mmHg 8 (6) 7
CVP D1, mmHg 7 (4) 7
CVP D2, mmHg 3 (0) 7
CVP D7, mmHg 6 (7) 7
Vasopressor use D0-7 5 (39) 4
Renal replacement therapy D0-7 0 7
Albumin 20% administration (100 mL) D 0-7 0 1
Corticosteroids use D -7-0 6 (43) 3
Corticosteroid use D 0-7 4 (29) 3
28-day mortality 2 (14) 1
Median (interquartile range) or number (percentage), where appropriate. Abbreviation
CVP-central venous pressure; D-day; ICU-intensive care unit; PaO2/FIO2-arterial O2 press
fied acute physiology score; SOFA-sequential organ failure assessment.those without ARDS (Berlin 0, P = 0.02). The PaO2/FIO2
ratio in patients without ARDS (Berlin 0) was lower than
in those with mild ARDS (Berlin 1, P = 0.001), but higher
than in Berlin categories 2 (P = 0.05) and 3 (P < 0.001)
(Table 2). Despite the relatively low PaO2/FIO2 ratio in
the Berlin 0 category these patients did not fulfill
the other prerequisites for ARDS. Similar variables
are presented for the LIS categories on D0 in Table 1.
According to the LIS, 14 (14%) patients had no
ARDS on D0, 69 (68%) mild, and 18 (18%) severe ARDS.egories of ARDS at baseline
2 3 P-value
= 9 N = 32 N = 7
1 (22) 63 (24) 69 (29) 0.21
(56) 20 (63) 5 (71) 0.60
9 (24) 49 (16) 44 (57) 0.39
(5) 9 (5) 10 (5) 0.06
(19) 8 (12) 9 (32) 0.98
(2) 6 (6) 7 (3) 0.26
(5) 7 (4) 6 (0) 0.83
(2) 6 (4) 5 (0) 0.25
(4) 7 (5) 9 (1) 0.49
(67) 23 (72) 5 (71) 0.20
(11) 4 (13) 0 0.57
(22) 8 (25) 0 0.03
(56) 14 (44) 3 (43) 0.92
(78) 16 (50) 4 (57) 0.28
(44) 10 (31) 3 (43) 0.15
IS 1.0-2.5 LIS >2.5
= 69 N =18 P-value
3 (24) 59 (28) 0.92
7 (68) 12 (67) 0.96
7 (20) 45 (23) 0.35
(5) 10 (3) 0.004
(9) 6 (12) 0.85
(5) 8 (5) 0.79
(6) 7 (4) 0.50
(3) 7 (6) 0.32
(5) 8 (3) 0.61
(63) 14 (82) 0.05
(10) 1 (6) 0.40
2 (17) 1 (6) 0.12
1 (45) 8 (44) 0.99
5 (51) 11 (61) 0.18
8 (26) 6 (33) 0.47
s: ARDS- acute respiratory distress syndrome; CPR- cardiopulmonary resuscitation;
ure over inspiratory O2 fraction; PEEP-positive end-expiratory pressure; SAPS-simpli-
Table 2 Ventilator course between days 0 and 7 according to Berlin and LIS categories of ARDS
Berlin category 0 1 2 3 P-value
N = 53 N = 9 N = 32 N = 7
Ventilator course D0-7
Mechanical ventilation D0 47 (89) 9 (100) 32 (100) 7 (100) 0.12
duration, days 22 (30) 23 (27) 22 (25) 16 (26) 0.85
PaO2/FIO2 ratio D0 180 (76) 226 (60) 155 (49) 89 (32) <0.001
PaO2/FIO2 ratio D1 191 (66) 208 (64) 156 (34) 91 (0) <0.001
PaO2/FIO2 ratio D2 194 (105) 252 (41) 168 (35) 68 (0) <0.001
PaO2/FIO2 ratio D7 189 (110) 239 (23) 161 (48) 73 (21) <0.001
PEEP D0, cmH20 8 (7) 8 (4) 10 (4) 10 (2) 0.10
PEEP D1, cmH20 8 (7) 8 (6) 10 (4) 13 (0) 0.13
PEEP D2, cmH20 8 (7) 10 (6) 10 (4) 8 (0) 0.40
PEEP D7, cmH20 6 (6) 11 (7) 9 (4) 13 (8) 0.001
Compliance D0, mL/cmH20 32 (23) 39 (13) 38 (23) 36 (27) 0.88
Compliance D1, mL/cmH20 39 (18) 35 (24) 35 (18) 21 (0) 0.24
Compliance D2, mL/cmH20 35 (20) 40 (30) 35 (20) 33 (0) 0.78
Compliance D7, mL/cmH20 47 (34) 31 (12) 37 (24) 19 (9) 0.11
Tidal volume D0, mL 500 (217) 500 (116) 520 (206) 530 (256) 0.92
Tidal volume D1, mL 520 (120) 500 (140) 500 (210) 530 (150) 0.68
Tidal volume D2, mL 520 (123) 500 (147) 505 (250) 550 (300) 0.78
Tidal volume D7, mL 530 (192) 463 (216) 500 (150) 450 (250) 0.17
Chest radiograph D0, quadrants 1 (1) 2 (0) 2 (1) 2 (1) <0.001
Chest radiograph D1, quadrants 1 (1) 2 (0) 2 (1) 2 <0.001
Chest radiograph D2, quadrants 1 (1) 2 (1) 2 (1) 3 <0.001
Chest radiograph D7, quadrants 0 (1) 2 (0) 2 (2) 3 (1) <0.001
LIS category LIS <1 LIS 1.0-2.5 LIS >2.5
N =14 N = 69 N =18 P-value
Ventilator course D0-7
Mechanical ventilation D0 10 (71) 67 (97) 18 (100) 0.001
duration, days 11 (20) 22 (27) 28 (21) 0.07
PaO2/FIO2 ratio D0 214 (130) 174 (68) 112 (70) <0.001
PaO2/FIO2 ratio D1 238 (157) 184 (60) 149 (40) <0.001
PaO2/FIO2 ratio D2 284 (111) 181 (72) 156 (48) <0.001
PaO2/FIO2 ratio D7 269 (162) 177 (79) 102 (78) <0.001
PEEP D0, cmH20 5 (2) 9 (6) 14 (3) <0.001
PEEP D1, cmH20 5 (1) 9 (4) 13 (4) <0.001
PEEP D2, cmH20 5 (1) 9 (5) 12 (6) <0.001
PEEP D7, cmH20 4 (3) 8 (6) 14 (5) <0.001
Compliance D0, mL/cmH20 44 (57) 39 (20) 27 (18) <0.001
Compliance D1, mL/cmH20 51 (25) 37 (18) 28 (21) <0.001
Compliance D2, mL/cmH20 61 (105) 35 (19) 31 (21) 0.01
Compliance D7, mL/cmH20 65 (75) 37 (24) 20 (11) 0.007
Tidal volume D0, mL 409 (268) 500 (176) 550 (154) 0.39
Tidal volume D1, mL 523 (177) 500 (166) 523 (95) 0.92
Hoeboer et al. BMC Pulmonary Medicine  (2015) 15:22 Page 5 of 13
Table 2 Ventilator course between days 0 and 7 according to Berlin and LIS categories of ARDS (Continued)
Tidal volume D2, mL 490 (138) 525 (133) 535 (194) 0.43
Tidal volume D7, mL 450 (150) 500 (213) 500 (138) 0.71
Chest radiograph D0, no quadrants 0 (1) 2 (1) 2 (3) <0.001
Chest radiograph D1, no quadrants 1 (1) 1 (1) 2 (2) <0.001
Chest radiograph D2, no quadrants 0 (1) 2 (1) 2 (3) <0.001
Chest radiograph D7, no quadrants 1 (0) 2 (1) 2 (1) 0.005
Median (interquartile range) or number (percentage), where appropriate. Abbreviations: ARDS- acute respiratory distress syndrome; D-day; ICU-intensive care unit;
PaO2/FIO2-arterial O2 pressure over inspiratory O2 fraction; PEEP-positive end-expiratory pressure.
Hoeboer et al. BMC Pulmonary Medicine  (2015) 15:22 Page 6 of 13In comparison to patients without lung injury, patients
with mild (LIS >1.0) or severe ARDS (LIS >2.5) were
more likely to need mechanical ventilation (P = 0.001
and P = 0.02), required more ventilator days (P = 0.04
and P = 0.03), and had a higher D0 SOFA score (P = 0.02
and P = 0.001; Table 2). On the day of inclusion an
ARDS risk factor (Table 3) was present in 93% of Berlin
ARDS patients and 96% of LIS ARDS patients, while
some patients suffered from more than one risk factor.
The correlation between the Berlin and LIS categories
was moderate (Rs = 0.54, P < 0.001) (Figure 1). Forty-one
patients had a Berlin category <1 and 6 patients had a
LIS ≤1 throughout the study.
Association with ARDS severity
Table 4 shows some associative values of D0 albumin and
CRP for the maximum Berlin and LIS categories within
one week after inclusion. During the week, 42 patients
reached a maximum Berlin <1 and 59 patients a max-
imum Berlin ≥1, whereas 6 patients reached a maximum
LIS ≤1 and 95 patients a maximum LIS >1. Patients with a
maximum Berlin ≥1 reached their maximum Berlin score
after day 0 in 30% of cases. Patients with a maximum LIS >1
reached their maximum LIS score after day 0 in 26% of
cases. The associative values of albumin ranged between
(AUROC) 0.62 to 0.65 (P = 0.04 or lower). An albumin level
<20 g/L was associated with a maximum Berlin category ≥1
and albumin <22 g/L was associated with a maximum LIS
>2.5. In contrast, CRP levels >138 mg/L were associated with
a maximum Berlin category ≥2 while CRP levels >81 mg/L
were associated with a maximum LIS >1.
Monitoring ARDS severity
Figure 2 presents values according to Berlin categories and
Figure 3 according to LIS categories in the course of time.
Of note, changing numbers per day indicate that ARDS
was deteriorating or improving over time in some pa-
tients. Albumin levels were lower and CRP levels were
higher with increasing Berlin and LIS category. The
albumin levels had a monitoring value, albeit moderate, on
all study days and cutoff values generally decreased with
increasing ARDS severity (AUROC between 0.62-0.82,
P < 0.001-0.03, Table 5). CRP levels had less frequentmonitoring value for ARDS severity. Figure 4 depicts the
change in albumin and CRP levels between D0 and 7
(ΔD0-7) in relation to the change in Berlin and LIS cat-
egory: albumin levels inversely related to change in ARDS
severity regardless of definition. Increasing CRP levels were
associated with increasing Berlin definition only. A decrease
in albumin of ≥1 g/L and an increase of CRP ≥104 mg/L
were associated with an increase in ARDS severity by Berlin
category (AUROC 0.72, P = 0.001 with sensitivity 100, spe-
cificity (SP) 42, positive predictive value (PPV) 23 and nega-
tive predictive value (NPV) 100%; AUROC 0.69, P = 0.04,
SN 27, SP 98, PPV 78 and NPV 88%, respectively). A
decrease in albumin ≥1 g/L was associated with an in-
crease in LIS category (AUROC 0.77, P < 0.001, SN 91, SP
54, PPV 26, NPV 97), and an increase in albumin ≥1 g/L
with a decrease in LIS category (AUROC 0.68, P = 0.02,
SN 61, SP 73, PPV 42, NPV 85).
Mortality
In 28-day non-survivors, D2 and peak LDH levels were
higher (647 (5005) and 756 (409) U/L, respectively,
P = 0.003) than in survivors (435 (199) and 543 (362) U/L,
respectively, P = 0.007). In patients with ARDS according to
the Berlin definition, LDH levels were higher in non-
survivors (665 (421) U/L) than in survivors (458 (243) U/L)
on D1 (P = 0.03), in non-survivors (706 (621) U/L) than in
survivors (452 (225) U/L) on D2 (P < 0.001), and in non-
survivors (618 (364) U/L) than in survivors (454 (258) U/L)
on D7 (P = 0.02). Peak LDH levels in non-survivors (876
(653) U/L) were higher than in survivors (581 (347) U/L,
P = 0.002). In patients with ARDS according to the LIS,
peak LDH levels in non-survivors (756 (409) U/L) were
higher than in survivors (548 (359) U/L, P = 0.009).
Albumin and CRP did not have prognostic significance.
Discussion
This longitudinal study in critically ill patients with or at
risk for ARDS with new onset fever suggests that albumin
rather than CRP levels are valuable in daily monitoring of
ARDS severity and course at the bedside. Although the as-
sociative values were only moderate, a low albumin was a
useful indicator on all study days, while a supranormal CRP
cutoff was less frequently associated with ARDS severity.
Table 3 ARDS risk factors on ICU admission and on study inclusion
Berlin category 0 1 2 3 P-value
N = 53 N = 9 N = 32 N = 7
ARDS risk factors on ICU admission
Sepsis 14 (26) 4 (44) 12 (38) 1 (14) 0.42
Shock 8 (15) 3 (33) 9 (28) 0 0.18
Trauma 11 (21) 0 2 (6) 0 0.09
General surgery 30 (57) 3 (33) 16 (50) 5 (71) 0.43
Vascular surgery 4 (8) 1 (1) 3 (9) 2 (29) 0.38
Cardiac surgery 3 (6) 0 2 (6) 1 (14) 0.69
Intracranial bleeding 10 (19) 2 (22) 1 (3) 1 (14) 0.19
CPR 6 (11) 1 (11) 2 (6) 1 (14) 0.86
Other 7 (13) 0 2 (6) 0 0.38
ARDS risk factors on D0
Sepsis 29 (56) 4 (44) 13 (41) 4 (57) 0.66
Shock 14 (26) 5 (56) 14 (44) 4 (57) 0.13
Pneumonia 3 (6) 0 4 (13) 2 (29) 0.14
Aspiration pneumonia 3 (6) 0 0 0 0.43
Peritonitis 3 (6) 1 (11) 1 (3) 0 0.71
Infected pancreatitis 2 (4) 0 1 (3) 0 0.89
Miscellaneous infection 20 (38) 2 (22) 10 (31) 3 (43) 0.75
Surgery within 48 hrs prior to inclusion 8 (15) 1 (11) 4 (13) 0 0.73
LIS category LIS ≤1.0 LIS 1.0-2.5 LIS >2.5 P-value
N =14 N = 69 N =18
ARDS risk factors on ICU admission
Sepsis 3 (21) 22 (32) 6 (33) 0.72
Shock 2 (14) 17 (25) 1 (6) 0.17
Trauma 1 (7) 10 (15) 2 (11) 0.73
General surgery 8 (57) 37 (54) 9 (50) 0.92
Vascular surgery 0 8 (11) 2 (11) 0.41
Cardiac surgery 0 4 (6) 2 (11) 0.42
Intracranial bleeding 5 (36) 7 (10) 2 (11) 0.04
CPR 1 (7) 7 (10) 2 (11) 0.93
Other 3 (21) 5 (7) 1 (6) 0.20
ARDS risk factors on D0
Sepsis 9 (64) 34 (49) 7 (39) 0.36
Shock 2 (14) 27 (39) 8 (44) 0.16
Pneumonia 1 (7) 6 (9) 2 (11) 0.92
Aspiration pneumonia 1 (7) 1 (2) 1 (6) 0.41
Peritonitis 1 (7) 3 (4) 1 (6) 0.90
Infected pancreatitis 2 (14) 1 (1) 0 0.03
Miscellaneous infection 7 (50) 25 (36) 3 (17) 0.13
Surgery within 48 hrs prior to inclusion 1 (7) 9 (13) 3 (17) 0.73
Number (percentage). Abbreviations: ARDS-acute respiratory distress syndrome; CPR-cardiopulmonary resuscitation; ICU-intensive care unit; hrs- hours; LIS-lung injury.
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Figure 1 Scatterplot of the Berlin definition categories vs. the lung injury score of ARDS (Rs = 0.54, P < 0.001).
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related to a change in ARDS severity regardless of def-
inition. In contrast, increasing CRP levels were associated
with increasing Berlin categories only. The LDH levels
only predicted 28-day mortality.
Only partial overlap between Berlin and LIS categories
has been observed before [1,4]. In the absence of a refer-
ence standard like autopsy or measurement of alveolar-Table 4 Diagnostic values of D0 albumin and CRP for maximu
onset fever in critically ill patients
AUROC 95% CI P-val
Maximum Berlin ≥1 (N = 59)
Albumin 0.65 0.53-0.76 0.01
Maximum Berlin ≥2 (N = 50)
Albumin 0.63 0.52-0.74 0.02
CRP 0.62 0.51-0.74 0.03
Maximum LIS >1.0 (N = 95)
CRP 0.82 0.64-1.00 0.002
Maximum LIS >2.5 (N = 34)
Albumin 0.62 0.51-0.73 0.04
Abbreviations: AUROC-area under the curve; ARDS-acute respiratory distress syndro
NPV-negative predictive value; PPV-positive predictive value; SN-sensitivity; SP- speccapillary permeability, we cannot determine whether the
Berlin categories underestimated or the LIS overesti-
mated the severity of ARDS. A relatively high PaO2/FIO2
ratio, in the presence of relatively high PEEP, may not
meet Berlin criteria if preconditions and bilaterality are
absent, whereas PEEP adds to the LIS score [3]. The sen-
sitivity of compliance, which is often the first parameter
to deteriorate after initiation of lung injury, even beforem Berlin and LIS categories within one week after new
ue Optimal cutoff SN SP PPV NPV
<20 g/L 71 58 71 58
<20 g/L 72 53 61 65
>138 mg/L 54 76 69 62
>81 mg/L 77 80 99 15
<22 g/L 91 31 41 87
me; CI-confidence interval; CRP-C-reactive protein; LIS- lung injury score;
ificity.
Figure 2 Median and inter quartile range of albumin and C-reactive protein (CRP) for the Berlin definition on ARDS. The Berlin categories
are inversely associated with albumin levels (P = 0.01) and directly with CRP levels (P = 0.02) in generalized estimating equations. ● no acute
respiratory distress syndrome (ARDS, Berlin 0), ■ mild ARDS (Berlin 1), ▲ moderate ARDS (Berlin 2) ▼ severe ARDS (Berlin 3). Numbers refer to
numbers of patients.
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of ARDS by LIS than Berlin definitions [31]. The Berlin
definition includes bilateral chest radiograph abnormal-
ities, while the LIS includes quadrants. However, chest
radiographs have high interobserver variability, leading
to frequent false positives and negatives [12,13]. As such
the LIS may constitute a more sensitive measure of the
clinical severity of ARDS correlating with alveolocapillary
permeability than the Berlin definition, but thereby carries
the risk of oversensitivity and overestimation [1,5], In any
case, the CVP was comparable between Berlin and LIS
categories, so it is less likely that severe fluid overload ex-
plains the difference in ARDS rating between definitions.Figure 3 Median and inter quartile range of albumin and C-reactive p
inversely associated with albumin (P < 0.001) and directly with CRP (P = 0.0
mild acute respiratory distress syndrome ARDS (LIS 1.0-2.5),▲ severe ARDSOtherwise, the rate and distribution of risk factors in this
population with or at risk for late ARDS in the ICU is in
agreement with the literature, showing ICU-acquired sep-
sis as the leading cause (Table 3) [1,14]. The relatively high
ARDS prevalence reflects the selection of critically ill pa-
tients with new onset fever, suggesting new onset sepsis or
inflammation both important ARDS risk factors.
We reasoned that an association with both ARDS se-
verity classifications would render a potential biomarker
clinically valuable, in the absence of a true reference
standard of ARDS. Albumin levels had monitoring value
for ARDS defined by the Berlin definition and the LIS
on all study days and cutoff values in AUROC’s declinedrotein (CRP) for the lung injury score (LIS). The LIS categories are
4) in generalized estimating equations. ● no lung injury (LIS ≤1.0), ■
(LIS >2.5). Numbers refer to numbers of patients.
Table 5 Monitoring values for ARDS severity on study days
AUROC 95% CI P-value Optimal cutoff SN SP PPV NPV
Berlin ≥1 day 0
Albumin 0.62 0.52-0.72 0.03 <20 g/L 71 51 58 65
day 1
Albumin 0.66 0.56-0.77 0.003 <20 g/L 84 44 55 77
day 2
Albumin 0.67 0.56-0.78 0.002 <17 g/L 67 65 58 73
day 7
Albumin 0.71 0.59-0.81 <0.001 <14 g/L 38 92 81 63
Berlin ≥2 day 1
Albumin 0.67 0.57-0.76 0.002 <18 g/L 73 54 44 80
day 2
Albumin 0.68 0.58-0.77 <0.001 <17 g/L 73 62 46 84
day 7
CRP 0.65 0.53-0.76 0.045 >105 mg/L 67 64 47 80
Berlin ≥3 day 7
Albumin 0.77 0.65-0.86 0.01 <18 g/L 100 49 10 100
CRP 0.91 0.82-0.97 <0.001 >162 mg/L 100 73 19 100
LIS >1 day 0
CRP 0.70 0.60-0.79 0.01 >81 mg/L 78 54 92 27
day 1
CRP 0.65 0.55-0.75 0.04 >182 mg/L 42 92 97 20
day 2
Albumin 0.82 0.73-0.89 <0.001 <21 g/L 86 64 94 43
day 7
Albumin 0.81 0.70-0.89 <0.001 <17 g/L 56 92 97 31
CRP 0.79 0.68-0.87 <0.001 >60 mg/L 68 79 93 36
LIS >2.5 day 1
Albumin 0.69 0.56-0.78 0.02 <11 g/L 39 96 70 88
day 7
Albumin 0.72 0.60-0.82 0.004 <18 g/L 83 53 26 94
CRP 0.83 0.73-0.91 <0.001 >158 mg/L 75 80 41 94
Abbreviations: AUROC-area under the receiver operating characteristics curve; CI-confidence interval; CRP-C-reactive protein; LIS-lung injury score; NPV-negative
predictive value; PPV-positive predictive value; SN-sensitivity-SP-specificity.
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that a low albumin is indeed involved in ARDS patho-
genesis, i.e. increased permeability edema, as suggested
before in cross-sectional studies [9,11,16-19]. Albumin
levels did not prognosticate outcome as in other studies
[18]. CRP levels had no consistent monitoring ability for
ARDS. A supranormal CRP was mainly associated with
severe ARDS on D7. Our data suggest that CRP is not
useful as a marker of ARDS severity and course, in line
with some studies [22,24]. However, in previous studies
CRP had value in differentiating ARDS from cardiogenic
pulmonary edema [23] and the CRP and LIS decline
upon successful ARDS treatment by corticosteroids [20].In our study, patients with cardiogenic edema were ex-
cluded. The use of corticosteroids on clinical indication
could have been a confounder but distribution between
ARDS categories was comparable. CRP levels did not
prognosticate outcome in our study in line with some
[22], but in contrast to reports on the association be-
tween elevated CRP levels and survival [21] or non-
survival [25]. Even though ARDS can be considered an
inflammatory response of the lung, numerous other fac-
tors can be responsible for elevated CRP levels in critically
ill patients. The levels of LDH, a marker of cell damage,
were not diagnostic of ARDS severity and course in line
with some [24], but in contrast to other observations
Figure 4 Changes of albumin and C-reactive protein (CRP) levels for changes in Berlin and lung injury score (LIS) categories between
D0-7. The change in albumin levels is associated with a change in Berlin and LIS category (P = 0.05 and P = 0.03, respectively). A change in CRP
levels is associated with a change in LIS category only (P = 0.03).
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to ARDS [26]. The LDH levels were however associated
with 28-day mortality, which has not been reported
before.
A limitation of this study is its relatively small sample
size and heterogeneous population. Considering general-
izabilty of the results the latter might be an advantage as
well. We included patients with the symptom fever ra-
ther than with specific conditions to focus on an inflam-
matory response as a major risk factor for developing or
worsening ARDS. Few patients received corticosteroids
or albumin as part of their treatment, but their distribu-
tion was equal between ARDS categories and therefore
do not invalidate our conclusions. With exceptions, the
AUROC’s were generally not >0.75. Low predictive cap-
acity could also be related to the inclusion of high risk
patients only. This must be weighed against the accessi-
bility of these variables which are collected almost dailyand routinely in many ICU’s. Nevertheless, even though
the associations between albumin levels and ARDS were
modest, they were present on all individual study days
and over the course of a week. Furthermore, albumin
was inversely related to disease severity regardless of the
clinical definition and its course predicted disease course
(AUROC 0.68-0.77 respectively), while neither albumin
nor CRP had any predictive value for 28-day mortality,
possibly due to the limited power of this study. Our
study suggests that albumin levels may have practical
value in monitoring the severity of ARDS at the bedside
of critically ill patients without the need for LIS calcula-
tions which are hardly done routinely. Assessing the
PaO2/FIO2 ratio and chest radiograph may be insufficient
to monitor ARDS, since both are treatment-dependent, for
instance with higher PaO2/FIO2 ratios and more aerated
chest radiographs with higher PEEP. Even though two au-
thors reviewed clinical history, chest radiographs, and CVP
Hoeboer et al. BMC Pulmonary Medicine  (2015) 15:22 Page 12 of 13to exclude severe fluid overload or congestive heart failure
in classifying alveolar consolidations we cannot fully
exclude a a component of hydrostatic edema in some
of our ARDS patients. Nevertheless, even when there is
dilution due to fluid administration hypoalbuminemia
leads to lowered oncotic pressure and in the presence
of increased vascular permeability this leads to pulmon-
ary edema and ARDS. As shown by others low total
protein and albumin levels, regardless of fluid state, are
associated with the presence and development of ARDS
[11,16,17]. Our study adds to the latter studies by fo-
cusing on the value of albumin in late ARDS (85-90%
after 48 hours, depending on definition) in the ICU, a
commonly underdiagnosed condition [14].
Conclusions
Overall, albumin rather than CRP may be valuable in pre-
dicting and monitoring the severity and course of ARDS in
febrile critically patients with or at risk for the syndrome.
Albumin levels below 20 g/L as well as a decline in albu-
min levels are associated with ARDS of increasing severity,
irrespective of definition. LDH levels predicted 28-day
mortality but had no monitoring value for ARDS severity.
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